Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition

Prostate

Volumn 42, Issue 1, 2000, Pages 45-55

  Shibata, Yasuhiro ^a   Ito, Kazuto ^a   Suzuki, Kazuhiro ^a   Nakano, Katsuya ^a   Fukabori, Yoshitatsu ^a   Suzuki, Ryota ^b   Kawabe, Yoshihiro ^b   Honma, Seijirou ^b   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Age; Endocrine environment; LC MS MS; Prostate; Quantitative analysis

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; AGE; AGED; AGING; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUANTITATIVE ASSAY; RAT; STEROID ANALYSIS; TISSUE LEVEL; VALIDATION PROCESS;

AGED; AGING; ANIMALS; DIHYDROTESTOSTERONE; ENDOCRINE GLANDS; ESTRADIOL; GONADAL STEROID HORMONES; HUMANS; MALE; PROSTATE; RATS; TESTOSTERONE;

EID: 0033989357     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000101)42:1<45::AID-PROS6>3.0.CO;2-W     Document Type: Article

References (36)

1. McConnell JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology. Philadelphia: W.B. Saunders; 1998. p 1429-1452.
2. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991;145:405-409.
3. Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, lifestyle, residence, diet, and activity. J Clin Endocrinol Metab 1984;59:955-961.
4. Mirovics JC, Dunlop M, Rennie GC. Changes in the pituitarytesticular system with age. Clin Endocrinol 1976;5:349-372.
5. Suzuki K, Takezawa Y, Suzuki T, Honma S, Yamanaka H. Synergistic effects of estrogen with androgen on the prostate effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. Prostate 1994;25:169-176.
6. Trachtenberg J, Hicks LL, Walsh PC. Androgen- and estrogenreceptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 1980;65:1051-1059.
7. Habenicht UF, Schwarz K, Schweikert HU, Neumann F, El Etreby MF. Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-7-dione: preliminay results. Prostate 1986;8:181-194.
8. Winter ML, Bosland MC, Wade DR, Falvo RE, Nagamani M, Liehr JG. Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5α-dihydrotestosterone and 17β-estradiol. Prostate 1995;26:325-333.
9. Suzuki K, Ito K, Tamura Y, Suzuki T, Honma S, Yamanaka H. Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings. Prostate 1996;28:328-337.
10. Zirkin BR, Coffey DS, Wheaton LG, Hiler ML, Bordy MJ, Niswender GD, Scott WW, Walsh PC. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest 1983;71:1114-1123.
11. Suzuki K, Inaba S, Takeuchi H. Endocrinal environment of benign prostatic hyperplasia - relationships of sex steroid hormone levels with age and the size of the prostate. Nippon Hinyokika Gakkai Zasshi 1992;83:664-671.
12. Ito K. The evidence of estrogen production in the prostate. Nippon Naibunpi Gakkai Zasshi 1996;72:1021-1033.
13. Rassaie MJ, Kumari GL, Rao PN, Shrivastav TG, Pandey HP. Influence of different combinations of antibodies and penicillinase-labeled testosterone derivatives on sensitivity and specificity of immunoassays. Steroids 1992;57:112-118.
14. Matsuki Y. Progress in mass spectrometric analysis of steroid conjugates LC/MS and MS/MS. Nippon Rinsho 1994;52:666-671.
15. 3 analog, and related compounds. In J Chromatogr B Biomed Sci Appl 1997;704:11-17.
16. Salerno R, Moneti G, Forti G, Magini A, Natali A, Saltutti C, Cello VD, Constantini A, Serio M. Simultaneous determination of testosterone, dihydrotestosterone and 5α-androstan-3α,-17β-diol by isotopic dilution mass spectrometry in plasma and prostatic tissue of patients affected by benign prostatic hyperplasia: effects of 3-month treatment with a GnRH analog. J Androl 1988;9:234-240.
17. Walsh PC, Hutchins GM, Ewing LL. Tissue content of dihydrotestosterone in human prostatic hyperplasia is not supranormai. J Clin Invest 1983;72:1772-1777.
18. Meikle AW, Stephenson RA, Lewis CM, Middleton RG. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metab 1997;82:571-575.
19. Suzuki K, Ito K, Ichinose Y, Kurokawa K, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration. Scand J Urol Nephrol 1995;29:65-68.
20. Takahashi Y, Yamanaka H, Honma S. The regulation system of brain aromatase activity; distribution and changes with age of the aromatase activity of the rat brain. Nippon Naibunpi Gakkai Zasshi 1987;63:862-863.
21. Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 1993;77:375-381.
22. Suzuki K, Takezawa Y, Suzuki T, Honma S, Yamanaka H. Synergistic effects of estrogen with androgen on the prostate effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. Prostate 1994;25:169-176.
23. Suzuki K, Ito K, Suzuki T, Honma S, Yamanaka H. Synergistic effects of estrogen and androgen on the prostate: effects of estrogen on androgen- and estrogen-receptors, BrdU uptake, immunohistochemical study of AR, and response to antiandrogens. Prostate 1995;26:151-163.
24. Vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagei SC, Dhar MD, Ganjam VK, Parmigiani S, Welshons WV. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997;94:2056-2061.
25. Schweikert HU, Tunn UW. Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia. Steroids 1987;50:1-3.
26. El Etreby MF, Nishino Y, Habenicht UF, Henderson D. Atamestane, a new aromatase inhibitor for the management of benign prostatic hyperplasia. J Androl 1991;12:403-414.
27. Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-5521.
28. Yeh S, Miyamoto H, Shima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 1998;95:5527-5532.
29. Bacher M, Rausch U, Goebel HW, Polzar B, Mannherz HG, Aumuller G. Stromal and epithelial cells from rat ventral prostate during androgen deprivation and estrogen treatment-regulation of transcription. Exp Clin Endocrinol 1993;101:78-86.
30. Nakhla AM, Khan MS, Romas NP, Rosner W. Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 1994;91:5402-5405.
31. Kuiper GGMJ, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930.
32. Kuiper GGMI. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-870.
33. Byers M, Kuiper GGJM, Gustafsson JA, Park-Sarge OK. Estrogen receptor-β mRNA expression in rat ovary: down regulation by gonadotropins. Mol Endocrinol 1997;11:172-182.
34. Mosselman S, Polman J, Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392:49-53.
35. Morioka M, Takeda K, Mitsuhata N, Ohashi T, Ohmori H. Endogenous androgen levels of human prostatic tissues. Nippon Naibunpi Gakkai Zasshi 1982;58:876-885.
36. Moneti G, Costantini A, Guarna A, Salerno R, Pazzagli M, Natali A, Goti A, Serio M. Measurement of testosterone and its 5-alfa-reduced metabolites in human prostatic tissue using isotope dilution mass spectrometry. J Steroid Biochem 1986;25:765-772.